IL160852A0 - Pharmaceutical compositions for the treatment of urinary disorders - Google Patents

Pharmaceutical compositions for the treatment of urinary disorders

Info

Publication number
IL160852A0
IL160852A0 IL16085202A IL16085202A IL160852A0 IL 160852 A0 IL160852 A0 IL 160852A0 IL 16085202 A IL16085202 A IL 16085202A IL 16085202 A IL16085202 A IL 16085202A IL 160852 A0 IL160852 A0 IL 160852A0
Authority
IL
Israel
Prior art keywords
treatment
pharmaceutical compositions
urinary disorders
urinary
disorders
Prior art date
Application number
IL16085202A
Other languages
English (en)
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/965,556 external-priority patent/US20030060513A1/en
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of IL160852A0 publication Critical patent/IL160852A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL16085202A 2001-09-27 2002-09-26 Pharmaceutical compositions for the treatment of urinary disorders IL160852A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/965,556 US20030060513A1 (en) 2001-09-27 2001-09-27 Pharmaceutical composition
SE0103858A SE0103858D0 (sv) 2001-09-27 2001-11-20 Pharmaceutical composition
PCT/SE2002/001748 WO2003026564A2 (en) 2001-09-27 2002-09-26 Pharmaceutical compositions for the treatment of urinary disorders

Publications (1)

Publication Number Publication Date
IL160852A0 true IL160852A0 (en) 2004-08-31

Family

ID=26655594

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16085202A IL160852A0 (en) 2001-09-27 2002-09-26 Pharmaceutical compositions for the treatment of urinary disorders

Country Status (9)

Country Link
EP (1) EP1438035A2 (ko)
JP (1) JP2005503424A (ko)
KR (1) KR20040039436A (ko)
CN (1) CN1558756A (ko)
BR (1) BR0212824A (ko)
CA (1) CA2461731A1 (ko)
IL (1) IL160852A0 (ko)
MX (1) MXPA04002496A (ko)
WO (1) WO2003026564A2 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
FR2843303B1 (fr) * 2002-08-07 2006-01-21 R & D Pharma Nouvelles compositions pharmaceutiques destinees au traitement de l'incontinence urinaire
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
CN100382794C (zh) * 2004-08-30 2008-04-23 鲁南制药集团股份有限公司 酒石酸托特罗定的分散片剂型
WO2009151613A1 (en) * 2008-06-13 2009-12-17 Concert Pharmaceuticals, Inc. Oxybutynin derivatives
EP2363397A4 (en) * 2008-11-07 2012-07-11 Dainippon Sumitomo Pharma Co NEW THERAPEUTIC AGENT USEFUL FOR SYMPTOM OF LOWER URINARY TRACT
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
KR20220009954A (ko) 2019-04-17 2022-01-25 컴퍼스 패쓰파인더 리미티드 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417135D0 (en) * 1994-08-23 1994-10-12 Medinnova S F Method
IT1282705B1 (it) * 1996-02-28 1998-03-31 Recordati Chem Pharm Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria
PE92198A1 (es) * 1996-08-01 1999-01-09 Banyu Pharma Co Ltd Derivados de 1,4-piperidina disustituida que contienen fluor
JP2001521000A (ja) * 1997-10-28 2001-11-06 メルク エンド カムパニー インコーポレーテッド 誘発性急性閉尿の予防
AU7703700A (en) * 1999-09-22 2001-04-24 Merck & Co., Inc. Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein
IT1314192B1 (it) * 1999-10-18 2002-12-06 Recordati Chem Pharm Derivati benzopiranici

Also Published As

Publication number Publication date
MXPA04002496A (es) 2004-05-31
CN1558756A (zh) 2004-12-29
KR20040039436A (ko) 2004-05-10
CA2461731A1 (en) 2003-04-03
WO2003026564A3 (en) 2003-12-11
WO2003026564A2 (en) 2003-04-03
WO2003026564A9 (en) 2004-06-17
EP1438035A2 (en) 2004-07-21
BR0212824A (pt) 2004-10-13
JP2005503424A (ja) 2005-02-03

Similar Documents

Publication Publication Date Title
IL157734A0 (en) Pharmaceutical compositions for the treatment of urogenital disorders
HUP0401514A3 (en) Pharmaceutical compositions for the treatment of asthma
ZA200401004B (en) Combination for the treatment of inflammatory disorders
GB0010669D0 (en) Compositions for treatment of disorders of the oesophagus
IL209842A0 (en) Compounds for the treatment of metabolic disorders
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
HUP0202719A3 (en) Pharmaceutical compositions for the treatment of female sexual dysfunctions
IL162485A0 (en) Compounds for the treatment of inflammatory disorders
AU2003274342A8 (en) Compositions for the treatment of autoimmune disorders
IL161070A0 (en) Compositions for the treatment of infectious diseases
AU2002356525A1 (en) Substituted amines for the treatment of neurological disorders
IL161267A0 (en) Combinations for the treatment of immunoinflammatory disorders
SI1432701T1 (sl) Uporaba heterociklicnih spojin pri zdravljenju bolezni urinarnega trakta
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
HUP0401427A3 (en) Oral compositions for the treatment of scalp disorders
EP1461030A4 (en) AMINOALKYL-BENZOFURAN-5-OL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA
IL160852A0 (en) Pharmaceutical compositions for the treatment of urinary disorders
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
AU2003283153A8 (en) Pharmaceutical compositions for the treatment of urinary incontinence
HUP0200253A2 (en) Pharmaceutical compositions for combination therapy
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
EP1402893A4 (en) MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SECONDARY PARATHYROID GLAND HYPERFUNCTION AND MEDICAMENTS FOR TREATING CARDIOVASCULAR COMPLICATIONS RELATED TO THE TREATMENT OF SECONDARY PARATHYROID GLAND HYPERFUNCTION
AU2002338849A1 (en) Pharmaceutical composition for the treatment of disorders of non-human mammals
GB0125371D0 (en) Treatment of movement disorders